Ozturk, KayhanErdur, OmerGul, OsmanOlmez, Ayse2020-03-262020-03-2620170023-852X1531-4995https://dx.doi.org/10.1002/lary.26557https://hdl.handle.net/20.500.12395/35130We performed endoscopic transoral neurectomy of the submandibular and sublingual glands to treat drooling. We bilaterally operated two adult cases with treatment-resistant drooling. In these patients, conventional treatment had failed. Repeated botilinum toxin type A (BOTOXVR, Abdi Ibrahim Pharmaceutical Company, Istanbul, Turkey) injections had been effective but were becoming less so. The patients benefited from surgery in that their saliva scores decreased. No issue emerged over 6 months of follow-up. Endoscopic transoral neurectomy of the submandibular and sublingual glands reduces saliva production and allows management of drooling in treatment-resistant patients.en10.1002/lary.26557info:eu-repo/semantics/closedAccessDroolingsialorrheasalivasubmandibular glandssublingual glandsArticle12771604160728304087Q1WOS:000403773900028Q2